As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer

NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science

After nearly three decades of reviewing NCI-funded extramural projects and sometimes saving NCI from its own folly, the Board of Scientific Advisors has been terminated as part of the Trump administration’s drive to reduce the size of the federal government.

May 02, 2025

Vol.51 No.17

By Paul Goldberg

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

“We stand at the edge of discovery, and on the brink of losing it,” said Patricia M. LoRusso, the 2024-2025 president of the American Association for Cancer Research. “I believe this is the most scientifically promising moment in the history of cancer research.”

May 02, 2025

Vol.51 No.17

By Claire Marie Porter

Cancer Policy

HHS ordered to cut 35% of spending on contracts

HHS spokesperson Andrew Nixon told NPR that HHS will reduce all contracts by 35%.

David Ryan named president of Mass General Brigham Cancer Institute

David Ryan was named the inaugural president of the Mass General Brigham’s Cancer Institute following a national search process.

May 02, 2025

Vol.51 No.17

Conversation with The Cancer Letter

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Over the past seven years, as Steven K. Libutti was designing the 12-story, $900-plus million cancer hospital in New Brunswick, NJ, he often thought of the functionality of the building that inspired it: Building 10, the NIH Clinical Center.

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models.

April 25, 2025

Vol.51 No.16

By Claire Marie Porter

As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer

YOU MAY BE INTERESTED IN

NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

HHS ordered to cut 35% of spending on contracts

David Ryan named president of Mass General Brigham Cancer Institute

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

Renew today!

Subscriber content

Never miss an issue!

Login

As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer

YOU MAY BE INTERESTED IN

NIH eliminates the NCI Board of Scientific AdvisorsOver its 28 year history, BSA shaped NCI-funded extramural science

Bertagnolli: NIH funding cuts are “unprecedented and harmful”AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

HHS ordered to cut 35% of spending on contracts

David Ryan named president of Mass General Brigham Cancer Institute

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

Never miss an issue!

Login

NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas